Skip to main content
Log in

Sarcopenia in Primary Care: Screening, Diagnosis, Management

  • Reviews
  • Published:
The Journal of Frailty & Aging Aims and scope Submit manuscript

Abstract

Detection of sarcopenia in primary care is a first and essential step in community-dwelling older adults before implementing preventive interventions against the onset of disabling conditions. In fact, leaving this condition undiagnosed and untreated can impact on the individual’s quality of life and function, as well as on healthcare costs. This article summarizes the many instruments today available for promoting an earlier and prompter detection of sarcopenia in primary care, combining insights about its clinical management. Primary care physicians may indeed play a crucial role in the identification of individuals exposed to the risk of sarcopenia or already presenting this condition. To confirm the suspected diagnosis, several possible techniques may be advocated, but it is important that strategies are specifically calibrated to the needs, priorities and resources of the setting where the evaluation is conducted. To tackle sarcopenia, nutritional counselling and physical activity programs are today the two main interventions to be proposed. Multicomponent and personalized exercise programs can (and should) be prescribed by primary care physicians, taking advantage of validated programs ad hoc designed for this purpose (e.g., the Vivifrail protocol). It is possible that, in the next future, new pharmacological treatments may become available for tackling the skeletal muscle decline. These will probably find application in those individuals non-responding to lifestyle interventions.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Similar content being viewed by others

References

  1. Rosenberg I, Roubenoff R. Stalking sarcopenia. Ann Intern Med, 1995;123(9):727–728.

    Article  CAS  PubMed  Google Scholar 

  2. Cao L, Morley JE. Sarcopenia Is Recognized as an Independent Condition by an International Classification of Disease, Tenth Revision, Clinical Modification (ICD-10-CM) Code. J Am Med Dir Assoc, 2016;17(8):675–677. doi:https://doi.org/10.1016/j.jamda.2016.06.001.

    Article  PubMed  Google Scholar 

  3. Beaudart C, McCloskey E, Bruyère O, et al. Sarcopenia in daily practice: assessment and management. BMC Geriatr, 2016;16(1):170. doi:https://doi.org/10.1186/s12877-016-0349-4.

    Article  PubMed  PubMed Central  Google Scholar 

  4. Calvani R, Miccheli A, Landi F, et al. Current nutritional recommendations and novel dietary strategies to manage sarcopenia. J Frailty Aging, 2013;2(1):16.

    Google Scholar 

  5. Beaudart C, Dawson A, Shaw S, et al. Nutrition and physical activity in the prevention and treatment of sarcopenia: systematic review. Osteoporos Int, 2017;28(6):1817–1833. doi:https://doi.org/10.1007/s00198-017-3980-9.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  6. Marzetti E, Sanna T, Calvani R, Bernabei R, Landi F, Cesari M. Brand New Medicine for an Older Society. J Am Med Dir Assoc, 2016;17(6):558–559. doi:https://doi.org/10.1016/j.jamda.2016.02.024.

    Article  PubMed  Google Scholar 

  7. Beaudart C, Rizzoli R, Bruyère O, Reginster J, Biver E. Sarcopenia: burden and challenges for public health. Arch Public Health, 2014;72(1):45.

    Article  PubMed  PubMed Central  Google Scholar 

  8. Cesari M, Fielding R, Bénichou O, et al. Pharmacological interventions in frailty and sarcopenia: report by the International Conference on Frailty and Sarcopenia Research task force. J Frailty Aging, 2015;4(3):114–120. doi:https://doi.org/10.14283/jfa.2015.64.

    CAS  PubMed  PubMed Central  Google Scholar 

  9. Cruz-Jentoft AJ, Landi F, Schneider SM, et al. Prevalence of and interventions for sarcopenia in ageing adults: a systematic review. Report of the International Sarcopenia Initiative (EWGSOP and IWGS). Age Ageing, 2014;43(6):748–759. doi:https://doi.org/10.1093/ageing/afu115.

    Article  PubMed  PubMed Central  Google Scholar 

  10. Englesbe MJ, Patel SP, He K, et al. Sarcopenia and Mortality after Liver Transplantation. J Am Coll Surg, 2010;211(2):271–278. doi:https://doi.org/10.1016/j.jamcollsurg.2010.03.039.

    Article  PubMed  PubMed Central  Google Scholar 

  11. Tan B, Birdsell L, Martin L, Baracos V, Fearon K. Sarcopenia in an overweight or obese patient is an adverse prognostic factor in pancreatic cancer. Clin Cancer Res, 2009;15(22):6973–6979. doi:https://doi.org/10.1158/1078-0432.CCR-09-1525.

    Article  CAS  PubMed  Google Scholar 

  12. Janssen I, Shepard D, Katzmarzyk P, Roubenoff R. The healthcare costs of sarcopenia in the United States. J Am Geriatr Soc, 2004;52(1):80–85. doi:https://doi.org/10.1111/j.1532-5415.2004.52014.x.

    Article  PubMed  Google Scholar 

  13. Sousa A, Guerra R, Fonseca I, Pichel F, Ferreira S, Amaral T. Financial impact of sarcopenia on hospitalization costs. Eur J Clin Nutr, 2016;70(9):1046–1051.

    Article  CAS  PubMed  Google Scholar 

  14. Janssen I. Skeletal Muscle Cutpoints Associated with Elevated Physical Disability Risk in Older Men and Women. Am J Epidemiol, 2004;159(4):413–421. doi:https://doi.org/10.1093/aje/kwh058.

    Article  PubMed  Google Scholar 

  15. Dent E, Morley J, Cruz-Jentoft A, et al. International Clinical Practice Guidelines for Sarcopenia (ICFSR): Screening, Diagnosis and Management. J Nutr Health Aging, 2018;22(10):1148–1161.

    Article  CAS  PubMed  Google Scholar 

  16. Malmstrom T, Morley J. SARC-F: a simple questionnaire to rapidly diagnose sarcopenia. J Am Med Dir Assoc, 2013;14(8):531–532. doi:https://doi.org/10.1016/j.jamda.2013.05.018.

    Article  PubMed  Google Scholar 

  17. Cruz-Jentoft A, Bahat G, Bauer J, et al. Sarcopenia: revised European consensus on definition and diagnosis. Age Ageing. 2019;48:16–31.

    Article  PubMed  Google Scholar 

  18. Morley JE, Cao L. Rapid screening for sarcopenia: Editorial. J Cachexia Sarcopenia Muscle, 2015;6(4):312–314. doi:https://doi.org/10.1002/jcsm.12079.

    Article  PubMed  PubMed Central  Google Scholar 

  19. Tosato M, Marzetti E, Cesari M, et al. Measurement of muscle mass in sarcopenia: from imaging to biochemical markers. Aging Clin Exp Res, 2017;29(1):19–27. doi:https://doi.org/10.1007/s40520-016-0717-0.

    Article  PubMed  Google Scholar 

  20. Heymsfield SB, Stanley A, Pietrobelli A, Heo M. Simple Skeletal Muscle Mass Estimation Formulas: What We Can Learn From Them. Front Endocrinol. 2020;11:31. doi:https://doi.org/10.3389/fendo.2020.00031.

    Article  Google Scholar 

  21. Tanaka T, Takahashi K, Akishita M, Tsuji T, Iijima K. Yubi-wakka” (finger-ring) test: A practical self-screening method for sarcopenia, and a predictor of disability and mortality among Japanese community-dwelling older adults. Geriatr Gerontol Int, 2017;18(2):224–232. doi:https://doi.org/10.1111/ggi.13163.

    Article  PubMed  Google Scholar 

  22. Roberts H, Denison H, Martin H, et al. A review of the measurement of grip strength in clinical and epidemiological studies: towards a standardised approach. Age Ageing, 2011;40(4):423–429.

    Article  PubMed  Google Scholar 

  23. Beaudart C, Rolland Y, Cruz-Jentoft AJ, et al. Assessment of Muscle Function and Physical Performance in Daily Clinical Practice: A position paper endorsed by the European Society for Clinical and Economic Aspects of Osteoporosis, Osteoarthritis and Musculoskeletal Diseases (ESCEO). Calcif Tissue Int. April 2019. doi:https://doi.org/10.1007/s00223-019-00545-w.

  24. Buckinx F, Croisier J, Reginster J, et al. Reliability of muscle strength measures obtained with a hand-held dynamometer in an elderly population. Clin Physiol Funct Imaging, 2017;37(3):332–340. doi:https://doi.org/10.1111/cpf.12300.

    Article  PubMed  Google Scholar 

  25. Damanti S, Azzolino D, Roncaglione C, Arosio B, Rossi P, Cesari M. Efficacy of Nutritional Interventions as Stand-Alone or Synergistic Treatments with Exercise for the Management of Sarcopenia. Nutrients, 2019;11(9):1991. doi:https://doi.org/10.3390/nu11091991.

    Article  CAS  PubMed Central  Google Scholar 

  26. Pedersen AN, Cederholm T. Health effects of protein intake in healthy elderly populations: a systematic literature review. Food Nutr Res, 2014;58(1):23364. doi:https://doi.org/10.3402/fnr.v58.23364.

    Article  CAS  Google Scholar 

  27. Pahor M, Guralnik J, Ambrosius W, et al. Effect of Structured Physical Activity on Prevention of Major Mobility Disability in Older Adults: The LIFE Study Randomized Clinical Trial. JAMA, 2014;311(23):2387–2396. doi:https://doi.org/10.1001/jama.2014.5616.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  28. Izquierdo M. [Multicomponent physical exercise program: Vivifrail]. Nutr Hosp. 2019;36(Spec No2):50–56. doi:https://doi.org/10.20960/nh.02680.

    PubMed  Google Scholar 

  29. Casas-Herrero A, Anton-Rodrigo I, Zambom-Ferraresi F, et al. Effect of a multicomponent exercise programme (VIVIFRAIL) on functional capacity in frail community elders with cognitive decline: study protocol for a randomized multicentre control trial. Trials, 2019;20(1):362. doi:https://doi.org/10.1186/s13063-019-3426-0.

    Article  PubMed  PubMed Central  Google Scholar 

  30. Marzetti E, Cesari M, Calvani R, et al. The “Sarcopenia and Physical fRailty IN older people: multi-componenT Treatment strategies” (SPRINTT) randomized controlled trial: Case finding, screening and characteristics of eligible participants. Exp Gerontol. 2018;113:48–57. doi:https://doi.org/10.1016/j.exger.2018.09.017.

    Article  PubMed  Google Scholar 

  31. Marzetti E, Calvani R, Landi F, et al. Innovative Medicines Initiative: The SPRINTT Project. J Frailty Aging. 2015;4:207–208.

    CAS  PubMed  PubMed Central  Google Scholar 

  32. Lardiés-Sánchez B, Sanz-París A, Pérez-Nogueras J, Serrano-Oliver A, Torres-Anoro ME, Cruz-Jentoft AJ. Influence of nutritional status in the diagnosis of sarcopenia in nursing home residents. Nutrition. 2017;41:51–57. doi:https://doi.org/10.1016/j.nut.2017.03.002.

    Article  PubMed  Google Scholar 

  33. Cederholm T, Jensen GL, Correia MITD, et al. GLIM criteria for the diagnosis of malnutrition — A consensus report from the global clinical nutrition community. Clin Nutr, 2019;38(1):1–9. doi:https://doi.org/10.1016/j.clnu.2018.08.002.

    Article  CAS  PubMed  Google Scholar 

  34. Cederholm T, Barazzoni R, Austin P, et al. ESPEN guidelines on definitions and terminology of clinical nutrition. Clin Nutr, 2017;36(1):49–64. doi:https://doi.org/10.1016/j.clnu.2016.09.004.

    Article  CAS  PubMed  Google Scholar 

  35. Phelan EA, Williams B, Snyder SJ, Fitts SS, LoGerfo JP. A five state dissemination of a communitybased disability prevention program for older adults. Clin Interv Aging, 2006;1(3):267–274. doi:https://doi.org/10.2147/ciia.2006.1.3.267.

    Article  PubMed  PubMed Central  Google Scholar 

  36. The “Geriatric Frailty Clinic (G.F.C) for Assessment of Frailty and Prevention of disability” Team, Tavassoli N, Guyonnet S, et al. Description of 1,108 older patients referred by their physician to the “Geriatric Frailty Clinic (G.F.C) for assessment of frailty and prevention of disability” at the gerontopole. J Nutr Health Aging, 2014;18(5):457–464. doi:https://doi.org/10.1007/s12603-014-0462-z.

    Article  Google Scholar 

  37. Deutz N, Bauer J, Barazzoni R, et al. Protein intake and exercise for optimal muscle function with aging: Recommendations from the ESPEN Expert Group. Clin Nutr, 2014;33(6):929–936. doi:https://doi.org/10.1016/j.clnu.2014.04.007.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  38. Bauer J, Biolo G, Cederholm T, et al. Evidence-Based Recommendations for Optimal Dietary Protein Intake in Older People: A Position Paper From the PROT-AGE Study Group. J Am Med Dir Assoc, 2013;14(8):542–559. doi:https://doi.org/10.1016/j.jamda.2013.05.021.

    Article  PubMed  Google Scholar 

  39. McDonald CK, Ankarfeldt MZ, Capra S, Bauer J, Raymond K, Heitmann BL. Lean body mass change over 6 years is associated with dietary leucine intake in an older Danish population. Br J Nutr, 2016;115(9):1556–1562. doi:https://doi.org/10.1017/S0007114516000611.

    Article  CAS  PubMed  Google Scholar 

  40. Muir S, Montero-Odasso M. Effect of vitamin d supplementation on muscle strength, gait and balance in older adults: a systematic review and meta-analysis. J Am Geriatr Soc, 2011;59(12):2291–2300. doi:https://doi.org/10.1111/j.1532-5415.2011.03733.x.

    Article  PubMed  Google Scholar 

  41. Beaudart C, Buckinx F, Rabenda V, et al. The Effects of Vitamin D on Skeletal Muscle Strength, Muscle Mass, and Muscle Power: A Systematic Review and Meta-Analysis of Randomized Controlled Trials. J Clin Endocrinol Metab, 2014;99(11):4336–4345. doi:https://doi.org/10.1210/jc.2014-1742.

    Article  CAS  PubMed  Google Scholar 

  42. Rooks D, Praestgaard J, Hariry S, et al. Treatment of Sarcopenia with Bimagrumab: Results from a Phase II, Randomized, Controlled, Proof-of-Concept Study. J Am Geriatr Soc, 2017;65(9):1988–1995. doi:https://doi.org/10.1111/jgs.14927.

    Article  PubMed  Google Scholar 

  43. Davidsen PK, Gallagher IJ, Hartman JW, et al. High responders to resistance exercise training demonstrate differential regulation of skeletal muscle microRNA expression. J Appl Physiol, 2011;110(2):309–317. doi:https://doi.org/10.1152/japplphysiol.00901.2010.

    Article  PubMed  Google Scholar 

  44. Hudelmaier M, Wirth W, Himmer M, Ring-Dimitriou S, Sänger A, Eckstein F. Effect of exercise intervention on thigh muscle volume and anatomical cross-sectional areas-quantitative assessment using MRI. Magn Reson Med, 2010;64(6):1713–1720.

    Article  PubMed  Google Scholar 

  45. Durheim MT, Slentz CA, Bateman LA, Mabe SK, Kraus WE. Relationships between exercise-induced reductions in thigh intermuscular adipose tissue, changes in lipoprotein particle size, and visceral adiposity. Am J Physiol-Endocrinol Metab, 2008;295(2):E407–E412. doi:https://doi.org/10.1152/ajpendo.90397.2008.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  46. Ebner N, Steinbeck L, Doehner W, Anker S, von Haehling S. Highlights from the 7th Cachexia Conference: muscle wasting pathophysiological detection and novel treatment strategies. J Cachexia Sarcopenia Muscle, 2014;5(1):27–34.

    Article  PubMed  PubMed Central  Google Scholar 

  47. Cruz-Jentoft A, Baeyens J, Bauer J, et al. Sarcopenia: European consensus on definition and diagnosis: Report of the European Working Group on Sarcopenia in Older People. Age Ageing, 2010;39(4):412–423. doi:https://doi.org/10.1093/ageing/afq034.

    Article  PubMed  PubMed Central  Google Scholar 

  48. Fielding R, Vellas B, Evans W, et al. Sarcopenia: an undiagnosed condition in older adults. Current consensus definition: prevalence, etiology, and consequences. International working group on sarcopenia. J Am Med Dir Assoc, 2011;12(4):249–256. doi:https://doi.org/10.1016/j.jamda.2011.01.003.

    Article  PubMed  Google Scholar 

  49. Morley J, Abbatecola A, Argiles J, et al. Sarcopenia with limited mobility: an international consensus. J Am Med Dir Assoc, 2011;12(6):403–409. doi:https://doi.org/10.1016/j.jamda.2011.04.014.

    Article  PubMed  PubMed Central  Google Scholar 

  50. Studenski S, Peters K, Alley D, et al. The FNIH Sarcopenia Project: Rationale, Study Description, Conference Recommendations, and Final Estimates. J Gerontol Ser A, 2014;69(5):547–558. doi:https://doi.org/10.1093/gerona/glu010.

    Article  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Silvia Crosignani.

Additional information

Conflicts of Interest

Matteo Cesari received honoraria from Nestlé for presentations at scientific meetings and as member of scientific advisory boards. No other conflict of interest declared by the Authors.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Crosignani, S., Sedini, C., Calvani, R. et al. Sarcopenia in Primary Care: Screening, Diagnosis, Management. J Frailty Aging 10, 226–232 (2021). https://doi.org/10.14283/jfa.2020.63

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.14283/jfa.2020.63

Key words

Navigation